Clinical trial
A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In…
NCT00478738 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00478738 |
|---|---|
| Title | A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In COPD Patients |
| Official title | A Study to Assess the Pharmacokinetics of Single Escalating Doses of Inhaled GSK961081 DPI (a Dual Pharmacophore) in Healthy Subjects (Part 1) and a Randomised, Double-blind, Double Dummy, Crossover (Incomplete Block) Study to Assess the Safety, Tolerability, Pharmacodynamics (Pulmonary and… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | GSK961081 |
| Enrollment | 82 |
| Start date | Jun 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | May 25, 2007 |
| Last update posted | Feb 2, 2017 |
| Countries | Germany, South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: